Northwestern University_Site number 124 — Chicago, Illinois

Northwestern University_Site number 124 is a clinical research site located in Chicago, Illinois, United States 60611.

Crixeo Clinical Trials Trust Score: 88/100 (GOOD). This profile has not yet been claimed by the site owner.

Northwestern University_Site number 124 has participated in 1 clinical trials.

Therapeutic areas: Diffuse Cutaneous Systemic Sclerosis.

Sponsors: Kadmon, a Sanofi Company.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Chicago

Browse all research sites in Illinois · View every site in Chicago

Sponsor Feasibility Report

Trust Score: 88/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Northwestern University_Site number 124?

Northwestern University_Site number 124 has a Crixeo Trust Score of 88/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Northwestern University_Site number 124 conducted?

Northwestern University_Site number 124 has 1 clinical trials on record. Their work covers Diffuse Cutaneous Systemic Sclerosis.

Is Northwestern University_Site number 124 accredited by Crixeo Clinical Trials?

Northwestern University_Site number 124 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Northwestern University_Site number 124?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.